We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+1.38%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$597M
AUM Growth
+$14.6M
Cap. Flow
+$7.12M
Cap. Flow %
1.19%
Top 10 Hldgs %
59.04%
Holding
391
New
40
Increased
56
Reduced
44
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDV icon
76
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.28B
$402K 0.07%
18,912
MRSH
77
Marsh
MRSH
$91.4B
$402K 0.07%
1,910
-396
-17% -$81.3K
IEF icon
78
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$397K 0.07%
4,242
+2,642
+165% +$245K
IEI icon
79
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
$396K 0.07%
3,429
+2,135
+165% +$245K
IBDT icon
80
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.06B
$367K 0.06%
14,811
+1,472
+11% +$36.3K
JPM icon
81
JPMorgan Chase
JPM
$955B
$361K 0.06%
1,786
VIGI icon
82
Vanguard International Dividend Appreciation ETF
VIGI
$9.18B
$357K 0.06%
4,396
-2,310
-34% -$185K
SCHE icon
83
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
$350K 0.06%
13,187
-8,814
-40% -$230K
IWR icon
84
iShares Russell Mid-Cap ETF
IWR
$57B
$338K 0.06%
4,166
-322
-7% -$26.2K
IBDR icon
85
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.39B
$336K 0.06%
14,123
+2
+0% +$47
IBDS icon
86
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
$324K 0.05%
13,653
IVW icon
87
iShares S&P 500 Growth ETF
IVW
$77.1B
$296K 0.05%
3,196
AJG icon
88
Arthur J. Gallagher & Co
AJG
$64.3B
$291K 0.05%
1,123
CVS icon
89
CVS Health
CVS
$126B
$278K 0.05%
4,706
+6
+0.1% +$375
IYW icon
90
iShares US Technology ETF
IYW
$24.9B
$276K 0.05%
1,835
PG icon
91
Procter & Gamble
PG
$342B
$270K 0.05%
1,640
HOG icon
92
Harley-Davidson
HOG
$2.76B
$268K 0.04%
8,000
IBDW icon
93
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.53B
$266K 0.04%
13,121
+2,860
+28% +$57.7K
CSCO icon
94
Cisco
CSCO
$479B
$260K 0.04%
5,475
-142
-3% -$6.74K
CRUS icon
95
Cirrus Logic
CRUS
$6.53B
$255K 0.04%
2,000
C icon
96
Citigroup
C
$231B
$254K 0.04%
4,000
BDJ icon
97
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.74B
$236K 0.04%
28,867
+14,446
+100% +$117K
VSS icon
98
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
$225K 0.04%
1,918
+23
+1% +$2.7K
ACN icon
99
Accenture
ACN
$104B
$221K 0.04%
727
NOW icon
100
ServiceNow
NOW
$121B
$220K 0.04%
1,400

Similar funds

Roble Belko & Company's Q2 2024 Portfolio in Review

As of Q2 2024, Roble Belko & Company held 391 positions worth $597M, up 2.5% from $583M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Roble Belko & Company's Q2 2024 filing shows 40 new, 56 increased, 44 reduced and 12 closed positions. Its largest new stake was State Street SPDR Portfolio Developed World ex-US ETF: 259,870 shares worth $9.12M. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $4.36M.

By sector, the portfolio is most concentrated in Technology at 2% of assets, down from 2.1% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Roble Belko & Company's largest Q2 2024 buy was State Street SPDR Portfolio Developed World ex-US ETF: 259,870 shares worth $9.12M.
  • Roble Belko & Company added most to Vanguard Total Bond Market in Q2 2024, an estimated $4.48M increase.
  • Roble Belko & Company's biggest Q2 2024 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $4.36M.
  • Roble Belko & Company fully exited Ares Capital in Q2 2024, selling an estimated $416K.
  • Roble Belko & Company's ten largest holdings make up 59% of its $597M portfolio in Q2 2024.
  • Roble Belko & Company opened 40 new positions and closed 12 in Q2 2024.
  • Roble Belko & Company's portfolio value rose 2.5% quarter-over-quarter to $597M.

Based on Roble Belko & Company's 13F filing for Q2 2024, filed 8 Aug 2024.